Carnosine in health and disease.


Journal

European journal of sport science
ISSN: 1536-7290
Titre abrégé: Eur J Sport Sci
Pays: England
ID NLM: 101146739

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 6 3 2018
medline: 19 4 2019
entrez: 6 3 2018
Statut: ppublish

Résumé

Carnosine was originally discovered in skeletal muscle, where it exists in larger amounts than in other tissues. The majority of research into the physiological roles of carnosine have been conducted on skeletal muscle. Given this and the potential for muscle carnosine content to be increased with supplementation, there is now a large body of research examining the ergogenic effects (or otherwise) of carnosine. More recent research, however, points towards a potential for carnosine to exert a wider range of physiological effects in other tissues, including the brain, heart, pancreas, kidney and cancer cells. Taken together, this is suggestive of a potential for carnosine to have therapeutic benefits in health and disease, although this is by no means without complication. Herein, we will provide a review of the current literature relating to the potential therapeutic effects of carnosine in health and disease.

Identifiants

pubmed: 29502490
doi: 10.1080/17461391.2018.1444096
doi:

Substances chimiques

Performance-Enhancing Substances 0
Carnosine 8HO6PVN24W

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

30-39

Auteurs

Guilherme Giannini Artioli (GG)

a Musculoskeletal Physiology Research Group, Sport, Health and Performance Enhancement (SHAPE) Research Centre , School of Science and Technology, Nottingham Trent University , Nottingham , UK.

Craig Sale (C)

a Musculoskeletal Physiology Research Group, Sport, Health and Performance Enhancement (SHAPE) Research Centre , School of Science and Technology, Nottingham Trent University , Nottingham , UK.

Rebecca Louise Jones (RL)

b School of Sport Science and Physical Activity, Institute for Sport and Physical Activity Research , University of Bedfordshire , Bedford , UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH